Foundation Medicine (NASDAQ: FMI) reported Q3 EPS of ($0.90), $0.02 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $29.4 million versus the consensus estimate of $28.7 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.